MAPK8 and cancer: SP600125 was used to study recovery from a number of the deregulated JNK pathway-associated diseases such as ischemia/reperfusion, cancer cell apoptosis, T2D, acute kidney injury, inflammation, viral infections, and sepsis-induced lung injury [27,197,206].